Zai Lab Limited (HKG:9688)
19.21
-0.79 (-3.95%)
Sep 10, 2026, 11:45 AM HKT
Zai Lab Employees
Zai Lab had 1,784 employees as of December 31, 2025. The number of employees decreased by 85 or -4.55% compared to the previous year.
Employees
1,784
Change (1Y)
-85
Growth (1Y)
-4.55%
Revenue / Employee
1.98M HKD
Profits / Employee
-827.35K HKD
Market Cap
22.37B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 1,784 | -85 | -4.55% | 1,784 | 0 |
| Dec 31, 2024 | 1,869 | -306 | -14.07% | 1,869 | 0 |
| Dec 31, 2023 | 2,175 | 139 | 6.83% | 2,175 | 0 |
| Dec 31, 2022 | 2,036 | 85 | 4.36% | 2,036 | 0 |
| Dec 31, 2021 | 1,951 | 757 | 63.40% | 1,951 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| 3SBio | 6,068 |
| Shanghai Henlius Biotech | 4,082 |
| Shanghai Junshi Biosciences | 3,055 |
| Keymed Biosciences | 1,768 |
| InnoCare Pharma | 1,388 |
| Ascentage Pharma Group International | 828 |
| InSilico Medicine Cayman TopCo | 333 |
| HBM Holdings | 327 |
Zai Lab News
- 13 days ago - Zai Lab price target raised to $36 from $27 at JPMorgan - TheFly
- 14 days ago - Z.ai shares surge 8% after releasing new AI model running only on Chinese chips - CNBC
- 18 days ago - Zai Lab (ZLAB) CFO Yajing Chen Sells 260 Shares, Insider Selling Trend Persists - GuruFocus
- 23 days ago - Zai Lab and Argenx announce results from Alkivia Phase 3 study - TheFly
- 23 days ago - Zai Lab and Argenx announce results from Alkivia Phase 3 study - TheFly
- 23 days ago - Zai Lab and argenx Announce Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis - Business Wire
- 27 days ago - Zai Lab (ZLAB) Q2 2026 Earnings Call Transcript - The Motley Fool
- 4 weeks ago - Zai Lab Q2 Earnings Call Highlights - MarketBeat